Catalyst Wire Dossier Catalyst Wire Dossier

Nalmefene Autoinjector 1.5 mg

Nalmefene · Purdue Pharma LP
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nalmefene Autoinjector 1.5 mg, covering 2025-07-03 to 2025-07-03. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacodynamic Evaluation of Intramuscular Nalmefene Autoinjector 1.5 mg Compared to Intranasal Narcan 4 mg [Phase 1]

See pricing